Results 161 to 170 of about 4,309 (206)

Crossing the barrier: nanomedicine as a frontier therapy for neuropathic Gaucher disease type 3. [PDF]

Ann Med Surg (Lond)
Saif M, Nasir A, Shafique S, Fatima M, Talha M.   +4 more
europepmc   +1 more source

The Unfolded Protein Response [PDF]

, 2018
Clarke, Emily Jayne
core  

Unraveling the role of GBA1 genotype in axial signs response to subthalamic deep brain stimulation. [PDF]

NPJ Parkinsons Dis
Bove F, Genovese D, De Biase A, Albanese A, Antonini A, Artusi CA, Avanzino L, Avenali M, Baldelli L, Calandra-Buonaura G, Cani I, Casasoli N, Cavallieri F, Cilia R, Cocco A, Colucci F, Di Biasio F, D'Onofrio V, Eleopra R, Fioravanti V, Giannini G, Golfre' Andreasi N, Guerra A, Imbalzano G, Izzo A, Ledda C, Liccari M, Lopiano L, Malaguti MC, Minardi R, Mitrotti P, Romito LM, Valente EM, Valzania F, Zangaglia R, Calabresi P, Piano C, Bentivoglio AR, Italian PARKNET Study.   +38 more
europepmc   +1 more source

Enzyme Activity-Based Genome-wide Screening for Modifiers of Lysosomal Glucocerebrosidase Uncovers Candidate Risk Factors for Parkinson's Disease. [PDF]

ACS Cent Sci
Udayar V, Gilormini PA, Bryois J, Gehrlein A, Chen X, Sonea S, Zhu S, Deen MC, Anastasi N, Murphy AE, Skene N, Tan MMX, Tunold JA, Roudnicky F, van de Berg WDJ, Pihlstrøm L, Vocadlo DJ, Jagasia R.   +17 more
europepmc   +1 more source

Should ITSN1 be considered as a Mendelian Parkinson's disease gene? Description of three novel families. [PDF]

NPJ Parkinsons Dis
Cogan G, Tesson C, Welment L, Clot F, LeGuern E, Lanore A, Dürr A, Cormier-Dequaire F, Debilly B, Planes M, Mangone G, Lesage S, Brice A.   +12 more
europepmc   +1 more source

Modelling cholinergic and dopaminergic function over time in Parkinson's disease with and without GBA1 variants. [PDF]

NPJ Parkinsons Dis
Slingerland S, de Meyer EKR, van der Horn HJ, Carli G, Slomp AC, d'Angremont E, Boertien JM, Goethals I, Meles SK, van der Zee S, van Laar T.   +10 more
europepmc   +1 more source

A multi-dimensional view on the etiology of Parkinson's disease. [PDF]

NPJ Parkinsons Dis
Bernhardt R, Schulze-Hentrich J.
europepmc   +1 more source

Correction: Deregulation of mTORC1-TFEB axis in human iPSC model of <i>GBA1</i>-associated Parkinson's disease. [PDF]

Front Neurosci
Mubariz F, Saadin A, Lingenfelter N, Sarkar C, Banerjee A, Lipinski MM, Awad O.   +6 more
europepmc   +1 more source

Metabolomic Changes in Idiopathic and GBA1 Parkinson’s Disease

Walton-Doyle C, Menozzi E, Schapira AH, Barran P.   +3 more
europepmc   +1 more source

Targeting Lysosomal pH Restores Mitochondrial Quality Control in GBA1-Mutant Parkinson’s Disease

Sheshadri P, Besada MAC, Fisher A, Kiraly S, Singh K, Kourouzidou I, Blacker TS, Zeng J, Shirihai OS, Grinstaff MW, Duchen MR.   +10 more
europepmc   +1 more source